Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Yang, P; Gilg, M; Evans, S; Totti, F; Stevenson, J; Jeys, L; Parry, M.
Survival of osteosarcoma patients following diagnosis of synchronous skip metastases.
J Orthop. 2020; 18:121-125 Doi: 10.1016/j.jor.2019.10.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Gilg Magdalena Maria
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: We aim to investigate the prognostic implications of synchronous skip metastases in osteosarcoma by presenting the largest single centre series to date. Retrospective study of 21 osteosarcoma patients with skip metastases treated between 1983 and 2004. No statistical difference in overall survival was demonstrated when comparing presence of lung metastases to those without (p = 0.859). No statistical difference was found in overall survival according to age group (<18yrs vs >18yrs; p = 0.126), or to percentage chemotherapy-induced bone necrosis (<90% vs >90%; p = 0.056). The presence of skip metastases confers a very poor prognosis as an independent variable. III. © 2019 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.
Find related publications in this database (Keywords): Skip metastases; Synchronous; Osteosarcoma; Survival